Skip to search formSkip to main contentSkip to account menu

bendamustine hydrochloride 25 MG Injection [Treanda]

Known as: BENDAMUSTINE HYDROCHLORIDE 25 mg in 5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TREANDA], TREANDA 25 MG Injection 
National Institutes of Health

Related topics

Related topics

5 relations
InjectionMannitolTreandabendamustine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation
Background High dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard of care for patients with… 
2011
2011
Cytotoxic Activity of Anti-CD20-hIFN-α on Rituximab-Resistant B-NHL Clones and Synergy with Chemotherapy,
Abstract 3499 Rituximab (chimeric anti-CD20 mAb) (Rtx) has been successfully used in the treatment of patients with B-cell non… 
2005
2005
Mitotic catastrophe induced in cells treated with SDX-105 (Treanda™)
2291 SDX-105 (Treanda™, bendamustine), an alkylating agent with a distinct mechanism of action, is active in NHL and CLL patients… 
2004
2004
SDX-105 (Treanda™), Active in Non-Hodgkin’s Lymphoma Cells, Induces the Mitotic Catastrophe Death Pathway.
SDX-105 (Treanda™) is an alkylating agent with a distinct mechanism of action that has been shown to be active in clinical trials… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)